Dr Jacinto I Manon, MD | |
5519 Doctors Dr, Edinburg, TX 78539-5563 | |
(956) 362-8500 | |
(956) 362-8505 |
Full Name | Dr Jacinto I Manon |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 21 Years |
Location | 5519 Doctors Dr, Edinburg, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326246638 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | S9740 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Doctors Hospital At Renaissance | Edinburg, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Renaissance Medical Foundation | 1153409867 | 86 |
News Archive
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
As the outbreak of H1N1 (Swine Flu) intensifies, there is a growing need for greater speed and accuracy in collecting specimens from patients for testing to determine with what they've been infected.
Gov. Gavin Newsom's first term in office has been defined by his response to the covid-19 pandemic, which has claimed the lives of more than 65,400 Californians.
When reminded of death, humans become more likely to support killing animals, regardless of their existing attitudes about animal rights, according to new research from the University of Arizona.
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
› Verified 7 days ago
Entity Name | Renaissance Medical Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467633867 PECOS PAC ID: 1153409867 Enrollment ID: O20080422000326 |
News Archive
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
As the outbreak of H1N1 (Swine Flu) intensifies, there is a growing need for greater speed and accuracy in collecting specimens from patients for testing to determine with what they've been infected.
Gov. Gavin Newsom's first term in office has been defined by his response to the covid-19 pandemic, which has claimed the lives of more than 65,400 Californians.
When reminded of death, humans become more likely to support killing animals, regardless of their existing attitudes about animal rights, according to new research from the University of Arizona.
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jacinto I Manon, MD Po Box 749, Pharr, TX 78577-1614 Ph: (956) 362-8500 | Dr Jacinto I Manon, MD 5519 Doctors Dr, Edinburg, TX 78539-5563 Ph: (956) 362-8500 |
News Archive
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. today announced the European Commission (EC) has granted orphan drug status for sirolimus (DE-109) for the treatment of chronic non-infectious uveitis.
As the outbreak of H1N1 (Swine Flu) intensifies, there is a growing need for greater speed and accuracy in collecting specimens from patients for testing to determine with what they've been infected.
Gov. Gavin Newsom's first term in office has been defined by his response to the covid-19 pandemic, which has claimed the lives of more than 65,400 Californians.
When reminded of death, humans become more likely to support killing animals, regardless of their existing attitudes about animal rights, according to new research from the University of Arizona.
Cardio3 BioSciences, soon to be renamed Celyad, a leader in engineered cell-therapy treatments today announced the infusion of the first patient enrolled in the Company's Phase I clinical trial evaluating the safety and feasibility of its NKG2D CAR T-cell therapy, in cancer patients suffering from acute myeloid leukemia (AML) or multiple myeloma (MM).
› Verified 7 days ago
Dr. Achal Patel, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 | |
Michael Burke, MD,FACS,FAAP Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2821 Michaelangelo Dr, Ste 200, Edinburg, TX 78539 Phone: 956-362-8215 Fax: 956-362-8219 | |
Dr. Juan Ed Torres-reveron, M.D./ PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 | |
Patricia Fernandez, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2821 Michaelangelo Dr Ste 304, Edinburg, TX 78539 Phone: 956-362-8501 Fax: 956-362-8505 | |
Dr. Jaime Gasco-tamarit, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4302 S Sugar Rd Ste 100, Edinburg, TX 78539 Phone: 956-292-0570 Fax: 956-292-0102 | |
Dr. Inad Badreddin Atassi, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5519 Doctors Dr, Edinburg, TX 78539 Phone: 956-362-8500 Fax: 956-362-8505 |